Loading…

Ethical considerations and palliative care in patients with amyotrophic lateral sclerosis: A review

Amyotrophic lateral sclerosis (ALS) is not a curable disease, but it is treatable. By definition, much of the care provided to ALS patients is palliative, even though active life-sustaining strategies are available to prolong survival. Healthcare professionals must develop communication skills that...

Full description

Saved in:
Bibliographic Details
Published in:Revue neurologique 2017-05, Vol.173 (5), p.300-307
Main Authors: Danel-Brunaud, V., Touzet, L., Chevalier, L., Moreau, C., Devos, D., Vandoolaeghe, S., Defebvre, L.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c362t-52c0067a6e56a906545c8f3e9180628069eb4bfc3e9087748429cb9c6496ae6f3
cites cdi_FETCH-LOGICAL-c362t-52c0067a6e56a906545c8f3e9180628069eb4bfc3e9087748429cb9c6496ae6f3
container_end_page 307
container_issue 5
container_start_page 300
container_title Revue neurologique
container_volume 173
creator Danel-Brunaud, V.
Touzet, L.
Chevalier, L.
Moreau, C.
Devos, D.
Vandoolaeghe, S.
Defebvre, L.
description Amyotrophic lateral sclerosis (ALS) is not a curable disease, but it is treatable. By definition, much of the care provided to ALS patients is palliative, even though active life-sustaining strategies are available to prolong survival. Healthcare professionals must develop communication skills that help patients cope with the inexorable progression of the disease and the inevitability of death. Symptomatic treatments as well as respiratory insufficiency and nutritional life-sustaining therapies must be regularly evaluated as the disease progresses, without losing sight of the burden placed on the patient's non-professional caregivers. The decision-making process regarding tracheostomy with invasive ventilation (TIV) is of greater complexity. Providing full information is crucial. Several long interviews are necessary to explain, discuss and allow assimilation of the information. Also, physicians should be careful not to focus exclusively on the biomedical aspects of disease, as ALS patients generally welcome the opportunity to discuss end-of-life issues with their physicians. Psychological factors, education level and cognitive status (especially the level of executive dysfunction) have a major influence on their decisions. However, as many patients do not complete advance directives with regard to TIV, advance care planning may instead be suggested in anticipation of emergency interventions. This should be discussed by healthcare professionals and the patient, and based on the wishes of the patient and caregiver(s), and communicated to all healthcare professionals. Many healthcare professionals are involved in the management of an ALS patient: they include not only those at ALS centers who provide diagnosis, follow-up and treatment initiation (particularly for respiratory and nutritional care), but also the medical and social care networks involved in disability support and home care. Specialist palliative care teams can work in partnership with ALS centers early in the course of the disease, with the center coordinating information-sharing and collaborative discussions.
doi_str_mv 10.1016/j.neurol.2017.03.032
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1896411129</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0035378716302296</els_id><sourcerecordid>1896411129</sourcerecordid><originalsourceid>FETCH-LOGICAL-c362t-52c0067a6e56a906545c8f3e9180628069eb4bfc3e9087748429cb9c6496ae6f3</originalsourceid><addsrcrecordid>eNp9kE1LAzEQhnNQbK3-A5EcvWzNx25240EopX5AwYueQzY7S1PS3ZqkLf33pmz1KEzIZHjfmcyD0B0lU0qoeFxPO9j53k0ZoeWU8BTsAo0J4UXGy6ocoesQ1oQwWhJ-hUasyktJGR0js4gra7TDpu-CbcDraFOGddfgrXbOpvcesNEesO1SKVroYsAHG1dYb4599P02dcBOx2R2OBgHvg82POEZ9rC3cLhBl612AW7P9wR9vSw-52_Z8uP1fT5bZoYLFrOCGUJEqQUUQksiirwwVctB0ooIlo6EOq9bkyqkKsu8ypk0tTQil0KDaPkEPQx9t77_3kGIamODAed0B_0uKFpJkVNKmUzSfJCa9NfgoVVbbzfaHxUl6oRUrdWAVJ2QKsJTsGS7P0_Y1Rto_ky_PJPgeRBA2jPt7lUwCZiBxnowUTW9_X_CD9uCjGw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1896411129</pqid></control><display><type>article</type><title>Ethical considerations and palliative care in patients with amyotrophic lateral sclerosis: A review</title><source>ScienceDirect Freedom Collection 2022-2024</source><creator>Danel-Brunaud, V. ; Touzet, L. ; Chevalier, L. ; Moreau, C. ; Devos, D. ; Vandoolaeghe, S. ; Defebvre, L.</creator><creatorcontrib>Danel-Brunaud, V. ; Touzet, L. ; Chevalier, L. ; Moreau, C. ; Devos, D. ; Vandoolaeghe, S. ; Defebvre, L.</creatorcontrib><description>Amyotrophic lateral sclerosis (ALS) is not a curable disease, but it is treatable. By definition, much of the care provided to ALS patients is palliative, even though active life-sustaining strategies are available to prolong survival. Healthcare professionals must develop communication skills that help patients cope with the inexorable progression of the disease and the inevitability of death. Symptomatic treatments as well as respiratory insufficiency and nutritional life-sustaining therapies must be regularly evaluated as the disease progresses, without losing sight of the burden placed on the patient's non-professional caregivers. The decision-making process regarding tracheostomy with invasive ventilation (TIV) is of greater complexity. Providing full information is crucial. Several long interviews are necessary to explain, discuss and allow assimilation of the information. Also, physicians should be careful not to focus exclusively on the biomedical aspects of disease, as ALS patients generally welcome the opportunity to discuss end-of-life issues with their physicians. Psychological factors, education level and cognitive status (especially the level of executive dysfunction) have a major influence on their decisions. However, as many patients do not complete advance directives with regard to TIV, advance care planning may instead be suggested in anticipation of emergency interventions. This should be discussed by healthcare professionals and the patient, and based on the wishes of the patient and caregiver(s), and communicated to all healthcare professionals. Many healthcare professionals are involved in the management of an ALS patient: they include not only those at ALS centers who provide diagnosis, follow-up and treatment initiation (particularly for respiratory and nutritional care), but also the medical and social care networks involved in disability support and home care. Specialist palliative care teams can work in partnership with ALS centers early in the course of the disease, with the center coordinating information-sharing and collaborative discussions.</description><identifier>ISSN: 0035-3787</identifier><identifier>DOI: 10.1016/j.neurol.2017.03.032</identifier><identifier>PMID: 28479121</identifier><language>eng</language><publisher>France: Elsevier Masson SAS</publisher><subject>ALS ; End of life ; Ethical considerations ; Motor neuron disease ; Palliative care ; Treatment restriction ; Treatment withdrawal</subject><ispartof>Revue neurologique, 2017-05, Vol.173 (5), p.300-307</ispartof><rights>2017 Elsevier Masson SAS</rights><rights>Copyright © 2017 Elsevier Masson SAS. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c362t-52c0067a6e56a906545c8f3e9180628069eb4bfc3e9087748429cb9c6496ae6f3</citedby><cites>FETCH-LOGICAL-c362t-52c0067a6e56a906545c8f3e9180628069eb4bfc3e9087748429cb9c6496ae6f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28479121$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Danel-Brunaud, V.</creatorcontrib><creatorcontrib>Touzet, L.</creatorcontrib><creatorcontrib>Chevalier, L.</creatorcontrib><creatorcontrib>Moreau, C.</creatorcontrib><creatorcontrib>Devos, D.</creatorcontrib><creatorcontrib>Vandoolaeghe, S.</creatorcontrib><creatorcontrib>Defebvre, L.</creatorcontrib><title>Ethical considerations and palliative care in patients with amyotrophic lateral sclerosis: A review</title><title>Revue neurologique</title><addtitle>Rev Neurol (Paris)</addtitle><description>Amyotrophic lateral sclerosis (ALS) is not a curable disease, but it is treatable. By definition, much of the care provided to ALS patients is palliative, even though active life-sustaining strategies are available to prolong survival. Healthcare professionals must develop communication skills that help patients cope with the inexorable progression of the disease and the inevitability of death. Symptomatic treatments as well as respiratory insufficiency and nutritional life-sustaining therapies must be regularly evaluated as the disease progresses, without losing sight of the burden placed on the patient's non-professional caregivers. The decision-making process regarding tracheostomy with invasive ventilation (TIV) is of greater complexity. Providing full information is crucial. Several long interviews are necessary to explain, discuss and allow assimilation of the information. Also, physicians should be careful not to focus exclusively on the biomedical aspects of disease, as ALS patients generally welcome the opportunity to discuss end-of-life issues with their physicians. Psychological factors, education level and cognitive status (especially the level of executive dysfunction) have a major influence on their decisions. However, as many patients do not complete advance directives with regard to TIV, advance care planning may instead be suggested in anticipation of emergency interventions. This should be discussed by healthcare professionals and the patient, and based on the wishes of the patient and caregiver(s), and communicated to all healthcare professionals. Many healthcare professionals are involved in the management of an ALS patient: they include not only those at ALS centers who provide diagnosis, follow-up and treatment initiation (particularly for respiratory and nutritional care), but also the medical and social care networks involved in disability support and home care. Specialist palliative care teams can work in partnership with ALS centers early in the course of the disease, with the center coordinating information-sharing and collaborative discussions.</description><subject>ALS</subject><subject>End of life</subject><subject>Ethical considerations</subject><subject>Motor neuron disease</subject><subject>Palliative care</subject><subject>Treatment restriction</subject><subject>Treatment withdrawal</subject><issn>0035-3787</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNp9kE1LAzEQhnNQbK3-A5EcvWzNx25240EopX5AwYueQzY7S1PS3ZqkLf33pmz1KEzIZHjfmcyD0B0lU0qoeFxPO9j53k0ZoeWU8BTsAo0J4UXGy6ocoesQ1oQwWhJ-hUasyktJGR0js4gra7TDpu-CbcDraFOGddfgrXbOpvcesNEesO1SKVroYsAHG1dYb4599P02dcBOx2R2OBgHvg82POEZ9rC3cLhBl612AW7P9wR9vSw-52_Z8uP1fT5bZoYLFrOCGUJEqQUUQksiirwwVctB0ooIlo6EOq9bkyqkKsu8ypk0tTQil0KDaPkEPQx9t77_3kGIamODAed0B_0uKFpJkVNKmUzSfJCa9NfgoVVbbzfaHxUl6oRUrdWAVJ2QKsJTsGS7P0_Y1Rto_ky_PJPgeRBA2jPt7lUwCZiBxnowUTW9_X_CD9uCjGw</recordid><startdate>201705</startdate><enddate>201705</enddate><creator>Danel-Brunaud, V.</creator><creator>Touzet, L.</creator><creator>Chevalier, L.</creator><creator>Moreau, C.</creator><creator>Devos, D.</creator><creator>Vandoolaeghe, S.</creator><creator>Defebvre, L.</creator><general>Elsevier Masson SAS</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201705</creationdate><title>Ethical considerations and palliative care in patients with amyotrophic lateral sclerosis: A review</title><author>Danel-Brunaud, V. ; Touzet, L. ; Chevalier, L. ; Moreau, C. ; Devos, D. ; Vandoolaeghe, S. ; Defebvre, L.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c362t-52c0067a6e56a906545c8f3e9180628069eb4bfc3e9087748429cb9c6496ae6f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>ALS</topic><topic>End of life</topic><topic>Ethical considerations</topic><topic>Motor neuron disease</topic><topic>Palliative care</topic><topic>Treatment restriction</topic><topic>Treatment withdrawal</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Danel-Brunaud, V.</creatorcontrib><creatorcontrib>Touzet, L.</creatorcontrib><creatorcontrib>Chevalier, L.</creatorcontrib><creatorcontrib>Moreau, C.</creatorcontrib><creatorcontrib>Devos, D.</creatorcontrib><creatorcontrib>Vandoolaeghe, S.</creatorcontrib><creatorcontrib>Defebvre, L.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Revue neurologique</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Danel-Brunaud, V.</au><au>Touzet, L.</au><au>Chevalier, L.</au><au>Moreau, C.</au><au>Devos, D.</au><au>Vandoolaeghe, S.</au><au>Defebvre, L.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Ethical considerations and palliative care in patients with amyotrophic lateral sclerosis: A review</atitle><jtitle>Revue neurologique</jtitle><addtitle>Rev Neurol (Paris)</addtitle><date>2017-05</date><risdate>2017</risdate><volume>173</volume><issue>5</issue><spage>300</spage><epage>307</epage><pages>300-307</pages><issn>0035-3787</issn><abstract>Amyotrophic lateral sclerosis (ALS) is not a curable disease, but it is treatable. By definition, much of the care provided to ALS patients is palliative, even though active life-sustaining strategies are available to prolong survival. Healthcare professionals must develop communication skills that help patients cope with the inexorable progression of the disease and the inevitability of death. Symptomatic treatments as well as respiratory insufficiency and nutritional life-sustaining therapies must be regularly evaluated as the disease progresses, without losing sight of the burden placed on the patient's non-professional caregivers. The decision-making process regarding tracheostomy with invasive ventilation (TIV) is of greater complexity. Providing full information is crucial. Several long interviews are necessary to explain, discuss and allow assimilation of the information. Also, physicians should be careful not to focus exclusively on the biomedical aspects of disease, as ALS patients generally welcome the opportunity to discuss end-of-life issues with their physicians. Psychological factors, education level and cognitive status (especially the level of executive dysfunction) have a major influence on their decisions. However, as many patients do not complete advance directives with regard to TIV, advance care planning may instead be suggested in anticipation of emergency interventions. This should be discussed by healthcare professionals and the patient, and based on the wishes of the patient and caregiver(s), and communicated to all healthcare professionals. Many healthcare professionals are involved in the management of an ALS patient: they include not only those at ALS centers who provide diagnosis, follow-up and treatment initiation (particularly for respiratory and nutritional care), but also the medical and social care networks involved in disability support and home care. Specialist palliative care teams can work in partnership with ALS centers early in the course of the disease, with the center coordinating information-sharing and collaborative discussions.</abstract><cop>France</cop><pub>Elsevier Masson SAS</pub><pmid>28479121</pmid><doi>10.1016/j.neurol.2017.03.032</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0035-3787
ispartof Revue neurologique, 2017-05, Vol.173 (5), p.300-307
issn 0035-3787
language eng
recordid cdi_proquest_miscellaneous_1896411129
source ScienceDirect Freedom Collection 2022-2024
subjects ALS
End of life
Ethical considerations
Motor neuron disease
Palliative care
Treatment restriction
Treatment withdrawal
title Ethical considerations and palliative care in patients with amyotrophic lateral sclerosis: A review
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T08%3A33%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Ethical%20considerations%20and%20palliative%20care%20in%20patients%20with%20amyotrophic%20lateral%20sclerosis:%20A%20review&rft.jtitle=Revue%20neurologique&rft.au=Danel-Brunaud,%20V.&rft.date=2017-05&rft.volume=173&rft.issue=5&rft.spage=300&rft.epage=307&rft.pages=300-307&rft.issn=0035-3787&rft_id=info:doi/10.1016/j.neurol.2017.03.032&rft_dat=%3Cproquest_cross%3E1896411129%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c362t-52c0067a6e56a906545c8f3e9180628069eb4bfc3e9087748429cb9c6496ae6f3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1896411129&rft_id=info:pmid/28479121&rfr_iscdi=true